About: Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $27.32 (+1.54%)
NBTX NASDAQ Nanobiotix
Nanobiotix share price
NBTX price activity
Last Price
$27.320
Change (24hr)
0.42 USD (1.54%)
Volume
178K
Volume (4w avg)
-
Open
$29.68
Day Range
$27.18 - $29.68
Previous Close
$26.90
Last Trade
19 Nov, 9:00 pm GMT+0
Delayed
19 Nov, 9:00 pm GMT+0
NBTX price performance
Delayed
19 Nov, 9:00 pm GMT+0
NBTX details
NBTX Market Signals